Pharmafile Logo

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

During the COVID-19 pandemic, multiple sclerosis (MS) experts were receiving many questions regarding the safety and efficacy of COVID-19 vaccination in patients receiving treatment for MS. The challenge was developing robust guidance in a timely manner with a goal of providing clarity on vaccine timing, efficacy, and safety, to support healthcare professionals and their patients.

An international Steering Committee of 10 MS experts came together to discuss, refine, and finalise 13 clinical recommendations. A further 28 MS experts from 19 countries also voted on the recommendations and helped to reach robust consensus through a virtual voting platform within a 90-day timeframe.

“Merck KGaA and Bedrock identified a beautifully simple solution to a pressing need. The judges recognised that achieving actional consensus on guidelines is always challenging, which is exacerbated by HCPs’ workloads, but the results achieved here are impressive. The approach was bold and imaginative, and the execution very well planned and delivered” PMEA Judging Panel 2022.

Stephen Marchant, MD of Bedrock said “We would like to add congratulations to Hashem Salloukh for partnering and trusting us with this critical project that provided a clear patient benefit. I would also like to thank my Bedrock team. This award is a testament to their freethinking, agility, and our belief that no two business challenges are the same.”

If you are looking for a team of freethinkers with bold and imaginative approaches to medical communications get in touch  freethinking@bedrock-health.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Bedrock mark International Batten Disease Awareness Day 2022 with Noah's Story

Emily Wigginton, Bedrock’s Head of Client Services, explains the inspiration behind the film designed to bring more awareness to the public about rare disease.

Shining a light on rare diseases with ‘Noah’s Story’

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Bedrock to raise awareness of Rare Disease Day 2022 with film 'Noah's Story'

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

ARISE - a strategic healthcare communication planning process from Bedrock

Bedrock Healthcare Communications MD Marie Little talks through the ARISE process and the clarity it brings to clients.

RESONANT GROUP ACQUIRES PR BUSINESS

Affirms Resonant’s mission to enable effective engagement in health

How can compelling healthcare communications support HCPs with their pandemic patient backlog?

Read our latest article, written by Chris Barton (Strategic Solutions Director), who shares his thoughts on how pharmaceutical companies and medical communication companies, like Bedrock, can support healthcare systems to...

5 top tips for adding creativity to medical writing

Learn from our Scientific Director, Stephanie Wasek, the secret to writing creative, compelling content for medical communications.

The future of dementia and the important role of healthcare communication in raising awareness

At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers

Bedrock’s strong start to 2021

Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.